medigraphic.com
ISSN 2078-7170 (Electronic)

2012, Number 4

<< Back Next >>

CorSalud 2012; 4 (4)

Percutaneous angioplasty with stent in the left main coronary artery

Rodríguez BS, Almeida GJ

Language: Spanish
References: 21
Page: 266-271
PDF size: 131.02 Kb.


ABSTRACT

Introduction and objective: Significant impairment of the left main coronary artery is the most lethal presentation of coronary artery disease. The treatment of choice is coronary artery bypass surgery. In several multicenter studies, the possibility of treating coronary artery disease by percutaneous coronary intervention with implantation of endoluminal prosthesis or stent is suggested. The objective of this research was to characterize percutaneous angioplasty with stent in the left main coronary artery. Method: An observational, descriptive and transversal study was carried out in 21 patients with percutaneous angioplasty with stent in the left main coronary artery, performed in the laboratory of Hemodynamics and Interventional Cardiology of Hermanos Ameijeiras Hospital, between January 2010 and July 2011. Results: There was no significant difference in sex. The age group 50-64 years (47.6%) and white skin color (76.19%) were predominant. The most commonly found cardiovascular risk factor was hypertension (85.71%), followed by dyslipidemia (47.61%). Effort angina was the most observed diagnosis with 14 cases (66.66%). The lesion in the body of the trunk (12 patients, 57.1%) was the most prevalent, followed by ostial lesion (8 cases). Drug-eluting (61.9%) was the most used type of stent and only 4 patients had surgically protected trunks. Conclusions: Most cases were elective, with a predominance of unprotected trunks. Hypertension was the coronary risk factor most commonly found. A significant association between diabetes mellitus and ostial location of the lesion was found.


REFERENCES

  1. García E, Sarnago F. Tratamiento percutáneo de la enfermedad del tronco coronario izquierdo en la era de los stents farmacoactivos. Rev Esp Cardiol. 2007;7(Supl E):57-62.

  2. Gruentzig AR, Sening A, Siegenthaler WE. Non operative dilatation of coronary artery: percutaneous transluminal coronary angioplasty. N Engl J Med. 1979;301:61-8.

  3. Price MJ, Cristea E, Sawhney N, Kao JA, Moses JW, Leon MB, et al. Serial angiographic follow-up of sirolimus-eluting stents for unprotected left main coronary artery revascularizatio. J Am Coll Cardiol. 2006;47(4):871-7.

  4. Silber S, Albersson P, Avilés F, Camici P, Colombo A, Hamn C, et al. Guidelines for percutaneous coro-nary interventions. The Task Force for Percuta-neous Coronary Interventions of the European So-ciety of Cardiology. Eur Heart J. 2005;26(8):804-47.

  5. Lansky AJ, Costa RA, Mintz GS, Tsuchiya Y, Midei M, Cox DA, et al. Non-polymer-based paclitaxel-coated coronary stents for the treatment of patients with de novo coronary lesions: angiographic follow-up of the DELIVER clinical trial. Circulation. 2004; 109(16):1948-54.

  6. Taggart DP, Kaul S, Boden WE, Ferguson TB Jr, Guyton RA, Mack MJ, et al. Revascularization for unprotected left main stem coronary artery stenosis stenting or surgery. J Am Coll Cardiol. 2008;51(9): 885-92.

  7. Zamora E, Delgado L, Castro MA, Fernández M, Orrit J, Romero B, et al. Cirugía coronaria con mini-circulación extracorpórea: experiencia de un grupo en España. Rev Esp Cardiol. 2008;61(4):376-81.

  8. Bautista-Hernández V, Gutiérrez F, Pinar E, Gime-no JR, Arribas JM, García-Puente J, et al. Experien-cia inicial con la asistencia ventricular izquierda tipo «Impella» para el shock cardiogénico poscardioto-mía y la angioplastia de tronco coronario izquierdo no protegido con baja fracción de eyección ventricu-lar izquierda. Rev Esp Cardiol. 2007;60(9):984-7.

  9. Meliga E, Garcia-Garcia HM, Valgimigli M, Chieffo A, Biondi-Zoccai G, Maree AO, et al. Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the DELFT (Drug Eluting stent for LeFT main) Registry. J Am Coll Cardiol. 2008; 51(23):2212-9.

  10. Buszman PE, Kiesz SR, Bochenek A, Peszek-Przybyla E, Szkrobka I, Debinski M, et al. Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization. J Am Coll Cardiol. 2008;51(5):538-45.

  11. Seung KB, Park DW, Kim YH, Lee SW, Lee CW, Hong MK, et al. Stents versus coronary-artery by-pass grafting for left main coronary artery disease. N Engl J Med. 2008;358(17):1781-92.

  12. Garg S, Serruys PW. Secondary revascularisation, mediations following the SYNTAX trial. Eurointer-vention. 2009;5(Suppl D):D14-20.

  13. Arnold JR, Banning AP. Stents versus bypass graf-ting for left main coronary artery disease. N Engl J Med. 2008 Jul 24;359(4):424-5

  14. Lozano I, García-Camarero T, Carrillo P, Bazd JA, de la Torre JM, López-Palo R, et al. Comparación de los stents liberadores de fármaco y los conven-cionales en puentes de safena. Resultados inme-diatos y a largo plazo. Rev Esp Cardiol. 2009; 62(Supl 1):101-16.

  15. O’Donnella CJ, Elosuac R. Factores de riesgo car-diovascular. Perspectivas derivadas del Framing-ham Heart Study. Rev Esp Cardiol. 2008;61(3):299-310.

  16. Kaneda H, Kataoka T, Ako J, Honda Y, Yock PG, Fitzgerald PJ. Coronary risk factors and coronary atheroma burden at severely narrowing segments. Int J Cardiol. 2008;124(1):124-6.

  17. Bachar GN, Atar E, Fuchs S, Dror D, Kornowski R. Prevalance and clinical predictors of atherosclerotic coronary artery disease in asymptomatic patients undergoing coronary multidetector computed tomo-graphy. Coron Artery Dis. 2007;18(5):353-60.

  18. Tacoy G, Balcioglu AS, Akinci S, Erdem G, Koca-man SA, Timurkaynak T, et al. Traditional risk fac-tors are predictive on segmental localization of coro-nary artery disease. Angiology. 2008;59(4):402-7.

  19. Costa MA, Perin E, Berger P, Block P, Katz S, Ramee S. Initial US experience on treatment of left main disease with sirolimus-eluting stents: insights from the e-Cypher post-marketing surveillance study. J Am Coll Cardiol. 2005;45:54A.

  20. Nakamura S, Muthusamy TS, Bae JH, Cahyadi YH, Udayachalerm W, Tresukosol D. Impact of siroli-mus-eluting stent on the outcome of patients with chronic total occlusions.Am J Cardiol. 2005;95(2): 161-6.

  21. Kastrati A, Mehilli J, Pache J, Kaiser C, Valgimigli M, Kelbaek H, et al. Analysis of 14 trials comparing sirolimuseluting stents with bare-metal stents. N Engl J Med. 2007;356(10):1030-9.




2020     |     www.medigraphic.com